CATHEPSIN-D CONCENTRATION IN BREAST-CANCER CYTOSOLS - CORRELATION WITH BIOCHEMICAL, HISTOLOGICAL, AND CLINICAL FINDINGS

被引:0
作者
DUFFY, MJ
BROUILLET, JP
REILLY, D
MCDERMOTT, E
OHIGGINS, N
FENNELLY, JJ
MAUDELONDE, T
ROCHEFORT, H
机构
[1] ST VINCENTS HOSP,DEPT MED ONCOL,DUBLIN 4,IRELAND
[2] NATL UNIV IRELAND UNIV COLL DUBLIN,DEPT SURG,DUBLIN 4,IRELAND
[3] FAC MED MONTPELLIER,INSERM,UNITE HORMONES & CANC,U148,F-34090 MONTPELLIER,FRANCE
[4] FAC MED MONTPELLIER,BIOL CELLULAIRE LAB,F-34090 MONTPELLIER,FRANCE
关键词
PROTEASE; ENZYME ACTIVITY; TUMOR MARKER; IMMUNORADIOMETRIC ASSAY;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Cathepsin D (CD, EC 3.4.23.5) is a lysosomal protease induced by estrogen in certain estrogen receptor (ER)-positive breast cancer cell lines but produced constitutively by ER-negative cell lines. Our aims in this investigation were to study the distribution of CD in human breast cancers and to relate its concentrations to various biochemical, histological, and clinical characteristics. The concentrations of CD were significantly higher in breast carcinomas than in either normal breast tissues or benign breast tumors. In primary carcinomas, CD concentrations did not correlate with the concentrations of ER or with the estrogen-inducible protease t-PA. However, CD concentrations did correlate weakly but significantly with both UK-PA antigen and UK-PA activity. Also, CD concentrations did not correlate with either tumor stage or axillary node status but did correlate significantly with tumor grade. Patients with cancers containing high concentrations of CD had a significantly shorter overall survival than did patients with low concentrations of the enzyme.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 22 条
  • [1] CAPONY F, 1989, CANCER RES, V49, P3904
  • [2] CAVAILLES V, 1987, J NATL CANCER I, V79, P245
  • [3] PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY
    CLARK, GM
    DRESSLER, LG
    OWENS, MA
    POUNDS, G
    OLDAKER, T
    MCGUIRE, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) : 627 - 633
  • [4] DUFFY MJ, 1983, CANCER, V51, P121, DOI 10.1002/1097-0142(19830101)51:1<121::AID-CNCR2820510124>3.0.CO
  • [5] 2-L
  • [6] DUFFY MJ, 1988, CANCER, V62, P531, DOI 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO
  • [7] 2-B
  • [8] DO PROTEASES PLAY A ROLE IN CANCER INVASION AND METASTASIS
    DUFFY, MJ
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05): : 583 - 589
  • [9] TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN BREAST-CANCER - RELATIONSHIP WITH ESTRADIOL AND PROGESTERONE RECEPTORS
    DUFFY, MJ
    OGRADY, P
    SIMON, J
    ROSE, M
    LIJNEN, HR
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 77 (03) : 621 - 623
  • [10] ESTROGENS, ESTRADIOL RECEPTORS AND PEROXIDASE-ACTIVITY IN HUMAN MAMMARY CARCINOMAS
    DUFFY, MJ
    OCONNELL, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1981, 17 (06) : 711 - 714